The mathematical form for a dose-time-response model is ideally not just a convenience for summarizing or fitting a particular data set-it represents a hypothesis. The more this hypothesis reflects a mechanistically sophisticated view of the likely reality, the more it can lead to potentially informative validating or invalidating types of predictions about the results of real experiments and (in the long run) reasonably credible predictions outside the range of direct observations. This paper first reviews some distinctive features of the nervous system and neurotoxic responses and theoretically explores some basic quantitative implications of these features. Relationships are derived for how dose-response relationships for the inhibition of function should depend on the numbers of neurons in series or redundant parallel arrangements that are required or capable of performing the function. Previous work is reviewed in which some less nervous-systemspecific features were the foci of quantitative risk-assessment modeling for specific neurotoxic end points. These include a) rates of repair of putatively reversible damage in the case of acrylamide; b) human interindividual variability in susceptibility to fetal/developmental effects in the case of methylmercury; and c) opportunities to use intermediate biomarkers to assist in integrated animal toxicological and epidemiologic investigations of the chronic cumulative risks posed by agents that contribute to neuronal loss with increasing age and pathology. -Environ Health Perspect 1 04(Suppl 2):381 -390 (1996) 
approaches to the problem of quantitative modeling of neurotoxic risks depart very seriously from the well-explored paradigm that has been used for quantitative risk assessment for genetically acting carcinogens. In particular, parameters measuring neurologic function are often continuous rather than quantal (3) , and there is a diverse set of modes of response of the nervous system to toxic insults (e.g., acute-reversible, acute-irreversible, chronicreversible, chronic-irreversible, latent-irreversible). Moreover, the observable modes of response often differ even for the same chemical as a function of dose rate and aggregated dose.
Quantitative risk assessment inevitably involves the projection of available information beyond the experimental or observational circumstances where it was collected. In general, an interpretive framework is imported from our background understanding of the system, and this is used to both select relevant data for analysis and interpret the significance of the data for the different circumstances in which we want to make risk predictions.
We can say that such a framework has a causal mechanistic basis to the extent that it arises from particular causal processes with defined quantitative implications. For example, some cases in which mechanistic understanding gives rise to particularly well-founded quantitative predictions include the following: * The high-concentration approach to saturation of Michaelis-Menten enzyme kinetics arises naturally from fundamental considerations of the finite binding capacity of protein molecules for substrates, and the finite processing times required for enzyme-catalyzed reactions (4). * Expectations of low-concentration linearity in chemical transport and reaction arise from fundamental consideration of mass action-the fact that all those processes ultimately result from the frequency of molecular collisions, which depends linearly on the concentration of each reactant (when temperature is held constant). * The development of physiologically based pharmacokinetic modeling over the last 20 years has been based on the recognition that the dynamics of transport and accumulation of simple organics in different body compartments can be at least approximately understood based on equilibrium partition coefficients, physical compartment sizes, and blood flow rates (5, 6 ). * The expectation of normal concentration distributions used in gaussian plume modeling (of the dispersion of air pollutants) arises ultimately from the central limit theorem: addition or subtraction of many random numbers yields a normal distribution. This is applied to air dispersion via the recognition that with air turbulence, individual molecules and small parcels of air are being subjected to many random translations in different directions, equivalent to addition and subtraction of random numbers. Similarly, where differences among individuals in internal body burdens of a toxicant arise from the multiplication of many random variables (e.g., concentration in an exposure medium such as fish; amount of the medium taken in; and residence time of the toxicant in the body) lognormal distributions are expected and frequently found (because multiplication or division of many random numbers is equivalent to the addition or subtraction of their logarithms) (7) . Similar reasoning has been used to support the traditional assumption of a lognormal distribution of thresholds used in log-probit dose-response analysis (8) for quantal noncancer effects.
The key point to understand is that the mathematical form for a dose-timeresponse model is ideally not just a convenience for summarizing or fitting a particular data set-it represents a hypothesis about the state of the world. The more this hypothesis reflects a mechanistically sophisticated view of the likely reality, the more it can lead to potentially informative vali (9, 10) . Moreover, model systems in which the behavioral effects of neurotoxic agents are found to be parallel to behavioral effects induced by specific physical lesions in specific neural areas show promise of providing a quantitative calibration of neurotoxic damage in terms of the location, extent, and severity of physically observable neuronal loss (11) .
Redundancy. For many tasks that the nervous system performs, excess capacity is available, at least in normal individuals. This means that performance on those tasks may not be proportionately degraded [or, depending on the measurement system, detectably degraded at all (12) ] in parallel with the loss or impairment of underlying functional elements. In combination with the normal age-related decline in neurons, this also is a likely cause of delays of many years in the manifestation of neurotoxic effects following an acute toxicant-induced injury.
Plasticity. To a considerable extent, when damage occurs to some elements, function can be recovered as surviving elements take on tasks formerly performed elsewhere (13) . In normal aging brains, neuronal loss appears to be substantially offset in terms of function by dendritic proliferation (14) . Other adaptive responses have also been noted at the subcellular level. Chronic exposure to anticholinesterase agents, leading to excessive transmission across cholinergic synapses, leads to compensatory down regulation of the number of receptors for acetylcholine on the postsynaptic membrane (15, 16 Let Pcell survival be the probability that an individual neuron survives an exposure to a toxicant in a particular time period. Pcell survival is, of course, a function of toxicant concentration; later we will use log probit and single-hit functions to represent this. Because all the cells acting in series must survive for a functional unit to remain active, we can expect that 'function preserved =(1cl survival)N [1] where Nis The following analysis focuses on the implications of the framework for the relationships between the structural variables and three measurable response parameters: a) the IF1O, the delivered dose required to reduce function by 10% (this will be close to the smallest reliably measurable response in many cases); b) the IF50, the delivered dose required to reduce function by 50%; and c) the IC50, the delivered dose required to inactivate 50% of the relevant cells (either reversibly or irreversibly, depending on the action of the toxicant under study).
The idea of delivered dose is included in these definitions as a reminder that the effects of any high-dose pharmacokinetic nonlinearities in the relationship between external dose and dose at the active site may need to be the subject of a separate modeling process.
Dose-Response Relationships for the Inactvation of Individual Cells
To derive predictions for the relationships among these response parameters as a function of the structural variables, the only added element we need is a dose-response relationship for cellular inactivation. A simple function that can be used for reference comparisons is classic one-hit inhibition, derived from the Poisson probability of each cell receiving various numbers of inactivating hits. P -P p _e-kd cell survival -0 hits- [4] where d is the dose of the toxicant, and k is the number of inhibitory hits per unit dose. This function would be expected to result from a mechanism in which the probability of inactivating damage to a vitally important organelle was a simple linear function of toxicant concentration x time at low doses. Setting (17) on the relationship between administered MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dose and dopamine concentrations in relevant regions of the brain in different species. Figure 1 shows the correspondence between the data and the fits done by Slikker and Gaylor (17) to a mathematical model of the form, Fraction of control dopamine concentration = I+ad [6] where d is dose and a is a fitted constant. Mechanistically, this model is best suited to the representation of concentrationresponse relationships for enzyme inhibition, where the dose or concentration of the toxicant producing 50% inhibition is 1/a. If, however, the action of MPTP is taken as primarily cell killing and if we assume that the fraction of control dopamine concentrations observed are a rough indication of the fraction of the relevant cells that have survived treatment, then a log probit fit to the data may yield a preliminary indication of the spread of the lognormal distribution of the thresholds of the relevant cells. A series of such fits to the same data used by Slikker and Gaylor (17) is shown in Figure 2 .
It should be immediately noted that it is not fair to directly compare the accuracy of the fits to the data in Figure 2 to those in Figure 1 . The probit model form used for Figure 2 has two adjustable parameters whereas the Slikker and Gaylor model form has only one. Figure 2 does not show a fit to the monkey data included in Figure  1 because, with only two data points, a two-parameter model must necessarily fit perfectly. The probit slope for such a fit to the monkey data is about 2, similar to that seen in Figure 2A .
The inference to be drawn from Figure  2 be expected to be spread out over a 100-fold range of values, from 10-fold less than the median to 10-fold greater than the median. A probit slope of 6 suggests a considerably narrower 95% range-approximately 4.6-fold, from a little more than half to a little more than double the median value. Figure 3 is We can now use Equation [3] to derive some expected relationships between the measurable parameters defined earlier. Figure 4 and Tables 1 and 2 show the consequences of parallel and series multiplicities based on the one-hit model of individual cellular sensitivities. It can be seen in Figure 4 that, as the number of redundant parallel units is increased (for a function dependent on only one cell in series), the dose-response curve for functional loss becomes increasingly sigmoidal in shape, and of course the IF50 (the dose required to produce a 50% loss of function) is progressively increased. Tables 1 and 2 show the effects of varying both redundancy and the length of the chain of cells in series. Tables 3 to 6 show the results of similar calculations for the One of the advantages of mechanistic modeling as an aid to basic scientific investigation is that when the predictions of a mechanistic model are refuted by subsequent observations, the direction of failure can provide mechanistically interpretable indications of potentially productive directions for further investigation. Work done some years ago explored the implications of a very simple model of the effects of repair of putatively reversible damage on dosetime-response data for acrylamide axonopathy (20) . The data sets analyzed were those that provided information on some specific manifestation of toxicity produced by different combinations of acrylamide dose rate and duration of exposure (21, 22) . The initial model for analyzing these data was built around three assumptions: a) a particular adverse effect occurs whenever a specific amount of damage is accumulated in the relevant portions of the nervous system (i.e., there is no appreciable delay between the production of damage and the manifestation of the resulting effects); b) damage is produced at a rate that is approximately linear with the mg per kg dose administered to the animals; and c) repair of the accumulated damage occurs at a rate that depends directly on the amount of accumulated damage that there is to be repaired.
The first assumption provided the primary tool for quantitatively analyzing the data. For each data set, the repair rate was found that made the amount of accumulated damage approximately equal for each of the dose and time combinations that were observed to produce a particular response. Figure 5 illustrates the buildup of internal damage to levels producing an effect under this model, with a 2.9% per day rate of repair.
Recently, new data have been analyzed by Hattis and Crofton (23) on the doserate and time responses of some motor activity end points for acrylamide neurotoxicity in rats both during and after the end of acrylamide dosing. Without knowledge of the posttreatment recovery results, the data for rate of loss of function for the period during dosing were fit to the initial model, and predictions were made for the times when various amounts of functional recovery should appear (23) . In all cases the predicted recovery times were distincdy less than the times observed for the actual recovery of various amounts of function.
Contrary to our model expectations, three out of the four sets of recovery measurements showed some appreciable lag time before recovery of function began to be observable ( Figure 6 ). The effect was most noticeable for the two highest dose rates and the most profound levels of functional impairment. Substitution of a saturable rather than a simple linear repair process improved the fit but did not make the theory compatible with the data.
The lack of adequate fit for these simple hypotheses leads us to some biologically interesting hypotheses for possible exploration in further work: * There might be functional compensation or adaptation by the organism to overcome partial damage to a component of the nervous system. * There might be a two-stage damage process, with the second stage of damage representing less easily reversible (or even irreversible) damage. For such a two-stage process, the need for acrylamide to act on the same neuron twice Unfortunately, in addition to statistical uncertainties in the determination of these slopes from limited data, there are important questions of biological interpretation. A conclusion that the relationships represented in the upper part of Table 7 represent true interindividual variability depends on an assumption that the biomarker of exposure used in this case-the maximum hair mercury found at any time during gestation-is the most appropriate direct causal predictor of response that can be developed. (Other possibilities might well include the concentration of mercury in maternal blood at a specific sensitive time during gestation or a weighted sum of concentrations x duration over a specific set of sensitive periods.) Any inaccuracy in the assessment of the relevant dose used for the analyses of Table 7 would tend to cause a bias in the estimation of the probit slopes toward lower values (and hence higher estimates of interindividual variability and low-dose risks).
In recent work, the relationship between uncertainty in the dosimeter and estimates of the probit slope has been quantitatively estimated (4) . It was found that measurement and estimation inaccuracies as large as a geometric standard deviation of 3 would be needed to make a true probit slope 6 relationship appear to have a probit slope as low as 1.
A further implication of this analysis is that if one were able to measure or estimate uncertainties in the individual doses estimated in epidemiological studies, it would be possible to at least make an approximate reconstruction of the slopes of the underlying dose-response relationships.
Quaifying and Tracing Causes of Early Damage in Chronic Cumulatve

Neurotoxic Processes
It has been stressed that neurons do not regenerate in adult life and that some important neurological conditions are caused by the chronic cumulative loss of specific types of neurons in older people. Because in many cases the brain can lose considerable numbers of the relevant cells before gross clinical signs of impairment are obvious, exposure to agents causing this category of conditions can proceed apparently innocuously for decades without being noticed. Even after symptoms Table 7 . Maximum likelihood log probit fitsa of fetal effects data using the method of Finney (8 (26) . bEstimated from data in the lowest one to three dose groups. cEstimated from the peak hair mercury data using the relationship ppb blood = 4*(ppm hair). dThe number of dose groups available for analysis, less 2 for the number of parameters estimated from the data (the intercept and probit slope). 'The probability that a deviation as large as that observed between the log probit model and the data would have been expected by chance, even if the log probit model were a perfect description of the underlying dose-response function. Many years ago Weiss and Spyker (29) suggested that methylmercury might accelerate the loss of neurons in adult life and contribute to a chronic cumulative process that could fall within this category. More recently, some support for this hypothesis has been found in a case-control epidemiologic study among people in Singapore, which has found an association between blood levels of mercury and risk of Parkinson's disease (30) . This finding, using a biomarker of exposure, needs to be followed up in confirmatory studies and (hopefully) with the aid of new biomarkers of the types suggested above.
